Patients and residents at The New Jewish Home’s Manhattan facility know Edianna Reyes Ovalle as a caring and talented Licensed Practical Nurse (LPN). What they don’t know is that this hard-working and dynamic health care hero had to overcome many obstacles to get where she is. And the support she got from The New Jewish Home’s Geriatrics Career Development (GCD) program made it possible.Read More
Ariana Schwartzberg, a student intern working at The New Jewish Home’s COVID-19 Recovery Unit in Manhattan, serves as a critical link between patients and their families in this facility, which is one of the few to receive this designation by the New York State Department of Health to exclusively care for patients with COVID-19. She is “a breath of fresh air,” says Manhattan Administrator Sandra Mundy, because she cares so deeply and is so helpful to staff and patients alike.Read More
Learn more about The New Jewish Home’s COVID-19 Recovery Unit, selected by the NY State Department of Health as a COVID-19 designated nursing home. Manhattan Administrator Sandra Mundy shares with Skilled Nursing News how the dedicated unit is helping patients recover from COVID-19. https://skillednursingnews.com/2021/03/inside-a-new-covid-only-nursing-home-and-why-theyre-still-necessary-a-year-into-covid-19/
The New Jewish Home is advocating to restore visitation for residents and families — these visits mean so much for families who long to see and hug their loved ones. Hear what Dr. Jeff Farber, The New Jewish Home’s President & CEO, has to say in these two news stories.
Jeff Farber interview on WINS:
In normal times, nursing home residents enjoy a wide range of social activities and companionship, in addition to visits from friends and family. But this pandemic year has been far from normal, with restricted visitation and limited group activities. A pilot program offered in conjunction with DOROT enabled some residents at The New Jewish Home’s Sarah Neuman campus in Westchester to take part in a series of friendly phone calls — while getting some much-needed relief from the isolation of the pandemic to boot.Read More
Roger Apperio was one of the first residents at The New Jewish Home to receive a promising new medication for COVID-19. Called monoclonal antibody treatment, it was authorized by the FDA just a few months ago and is already benefitting people who have been diagnosed with COVID and who are at high risk for progressing to severe disease.Read More